811 followers
RT @FrontOncology: New research: Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma: Combined hepato…
RT @FrontOncology: New research: Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma: Combined hepato…
New research: Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma: Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare subtype of primary liver cancers. Therapeutic strategies for patients with… #oncology h